Product Description
Proteomic Biomarker Analytics Markets: Forecasts by Application, Technology, Product and Place with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2022 to 2026
Publication date: October 27, 2022
Pages: 251
“Proteomic analytics is replacing genomics as the new frontier in biotechnology. Early days hold plenty of opportunity with completely new types of biomarkers already at work…..”
Proteomics is going mainstream. Where genomics couldn’t find all the answers, proteomics is stepping up to the plate.
- Who will be the Illumina of proteomics?
- Will these new biomarkers redefine disease definitions?
- Will proteomic assays displace current genomic assays?
Understand the answers to these questions and more in this comprehensive market report.
Proteomic biomarker analytics is just finding its feet, but the opportunity is to understand the front line players, with the actual proteins and protein complexes that do the work of managing cellular life. Players are reporting double digit growth with Venture Capital well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time.
The report forecasts the market size out five years by country for a number of different market segments, including:
- Application
- Drug discovery
- Research
- Clinical diagnostics
- Other
- Technology
- Mass Spectrometry
- ELISA/Beads
- Hybrid multiplex
- Other
- Product
- Instruments
- Kits and reagents
- Services
- Place
- Academic
- Pharma and biotech
- Clinical
- Other
Additional country breakouts can be requested as part of the corporate license.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional and co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell is a member of The American Association for Clinical Chemistry. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School
